Humanized mouse models to study human diseases

Purpose of reviewUpdate on humanized mouse models and their use in biomedical research. Recent findingsThe recent description of immunodeficient mice bearing a mutated IL-2 receptor gamma chain (IL2rγ) facilitated greatly the engraftment and function of human hematolymphoid cells and other cells and tissues. These mice permit the development of human immune systems, including functional T and B cells, following engraftment of hematopoietic stem cells (HSCs). The engrafted functional human immune systems are capable of T and B cell-dependent immune responses, antibody production, antiviral responses, and allograft rejection. Immunodeficient IL2rγnull mice also support heightened engraftment of primary human cancers and malignant progenitor cells, permitting in-vivo investigation of pathogenesis and function. In addition, human-specific infectious agents for which animal models were previously unavailable can now be studied in vivo using these new-generation humanized mice. SummaryImmunodeficient mice bearing an IL2rγnull mutated gene can be engrafted with functional human cells and tissues, including human immune systems, following engraftment with human hematolymphoid cells. These mice are now used as in-vivo models to study human hematopoiesis, immunity, regeneration, stem cell function, cancer, and human-specific infectious agents without putting patients at risk.

[1]  Raymond Dunn,et al.  NOD-scid IL2r&ggr;null Mouse Model of Human Skin Transplantation and Allograft Rejection , 2010, Transplantation.

[2]  伊藤 旭.  Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2Rγ[null] mice in vivo , 2010 .

[3]  M. Tankersley,et al.  T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice , 2009, Pediatrics.

[4]  Russell J. Taylor,et al.  Bioluminescent Imaging Demonstrates That Transplanted Human Embryonic Stem Cell‐Derived CD34+ Cells Preferentially Develop into Endothelial Cells , 2009, Stem cells.

[5]  A. Rothman,et al.  Dengue Virus Infection and Virus-Specific HLA-A2 Restricted Immune Responses in Humanized NOD-scid IL2rγnull Mice , 2009, PloS one.

[6]  S. Gerber,et al.  Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/gammac-/-, Balb/c-Rag1-/-gammac-/-, and C.B-17-scid/bg immunodeficient mice. , 2009, Human immunology.

[7]  S. Iida,et al.  Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2Rγnull Mice In Vivo1 , 2009, The Journal of Immunology.

[8]  M. Manz,et al.  Renaissance for mouse models of human hematopoiesis and immunobiology , 2009, Nature Immunology.

[9]  Sebastian Reuter,et al.  Protection from graft-versus-host disease by HIV-1 envelope protein gp120-mediated activation of human CD4+CD25+ regulatory T cells. , 2009, Blood.

[10]  R. Hotchkiss,et al.  Sepsis‐induced human lymphocyte apoptosis and cytokine production in “humanized” mice , 2009, Journal of leukocyte biology.

[11]  M. Manns,et al.  Humanized mice for modeling human infectious disease: challenges, progress, and outlook. , 2009, Cell host & microbe.

[12]  L. Shultz,et al.  Improved Murine Model of Malaria Using Plasmodium falciparum Competent Strains and Non-Myelodepleted NOD-scid IL2Rγnull Mice Engrafted with Human Erythrocytes , 2009, Antimicrobial Agents and Chemotherapy.

[13]  C. Civin,et al.  Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand1 , 2009, The Journal of Immunology.

[14]  Mamoru Ito,et al.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). , 2009, International immunology.

[15]  H. Hammad,et al.  Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC‐derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation , 2009, Allergy.

[16]  D. Greiner,et al.  Human peripheral blood leucocyte non‐obese diabetic‐severe combined immunodeficiency interleukin‐2 receptor gamma chain gene mouse model of xenogeneic graft‐versus‐host‐like disease and the role of host major histocompatibility complex , 2009, Clinical and experimental immunology.

[17]  H. Mitsuya,et al.  Potent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine, against Human Immunodeficiency Virus Type 1 Infection in a Model Using Human Peripheral Blood Mononuclear Cell-Transplanted NOD/SCID Janus Kinase 3 Knockout Mice , 2009, Antimicrobial Agents and Chemotherapy.

[18]  C. Rice,et al.  Priming of protective T cell responses against virus-induced tumors in mice with human immune system components , 2009, The Journal of experimental medicine.

[19]  M. Sykes,et al.  Induction of Human T‐Cell Tolerance to Pig Xenoantigens via Thymus Transplantation in Mice with an Established Human Immune System , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  Andrew D. Luster,et al.  Induction of Robust Cellular and Humoral Virus-Specific Adaptive Immune Responses in Human Immunodeficiency Virus-Infected Humanized BLT Mice , 2009, Journal of Virology.

[21]  G. Linette,et al.  Immunodeficient Mouse Strains Display Marked Variability in Growth of Human Melanoma Lung Metastases , 2009, Clinical Cancer Research.

[22]  J. Pober,et al.  Development of a Humanized Mouse Model to Study the Role of Macrophages in Allograft Injury , 2009, Transplantation.

[23]  J. Garcia,et al.  Novel humanized murine models for HIV research , 2009, Current HIV/AIDS reports.

[24]  J. D. Di Santo,et al.  IL-15 trans-presentation promotes human NK cell development and differentiation in vivo , 2009, The Journal of experimental medicine.

[25]  B. Berkhout,et al.  Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2-/-γc-/-) mouse model , 2009, Gene Therapy.

[26]  S. Iida,et al.  Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model , 2008, Cancer Immunology, Immunotherapy.

[27]  G. Pruneri,et al.  Human acute leukemia cells injected in NOD/LtSz‐scid/IL‐2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid‐related strains , 2008, International journal of cancer.

[28]  D. Greiner,et al.  Non‐obese diabetic–recombination activating gene‐1 (NOD–Rag 1 null) interleukin (IL)‐2 receptor common gamma chain (IL 2 rγnull) null mice: a radioresistant model for human lymphohaematopoietic engraftment , 2008, Clinical and experimental immunology.

[29]  J. Banchereau,et al.  Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. , 2008, Blood.

[30]  R. Woodland,et al.  Human BLyS Facilitates Engraftment of Human PBL Derived B Cells in Immunodeficient Mice , 2008, PloS one.

[31]  B. Levine,et al.  CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function1 , 2008, The Journal of Immunology.

[32]  R. Steinman,et al.  Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. , 2008, Blood.

[33]  J. Lief,et al.  A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function , 2008, Diabetologia.

[34]  R. J. Kelleher,et al.  Long-Term Engraftment and Expansion of Tumor-Derived Memory T Cells Following the Implantation of Non-Disrupted Pieces of Human Lung Tumor into NOD-scid IL2Rγnull Mice1 , 2008, The Journal of Immunology.

[35]  D. Greiner,et al.  Creation of “Humanized” Mice to Study Human Immunity , 2008, Current protocols in immunology.

[36]  G. Weir,et al.  Pig islet xenograft rejection in a mouse model with an established human immune system , 2008, Xenotransplantation.

[37]  R. Woodland,et al.  A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. , 2008, Clinical immunology.

[38]  D. Greiner,et al.  Humanized SCID mouse models for biomedical research. , 2008, Current topics in microbiology and immunology.

[39]  H. Spits,et al.  Experimental model for the study of the human immune system: production and monitoring of "human immune system" Rag2-/-gamma c-/- mice. , 2008, Methods in molecular biology.

[40]  J. Church.  Upregulation of PD-1 Expression on HIV-Specific CD8+ T Cells Leads to Reversible Immune Dysfunction , 2007, Pediatrics.

[41]  J. Banga,et al.  Application of HLA class II transgenic mice to study autoimmune regulation. , 2007, Thyroid : official journal of the American Thyroid Association.

[42]  M. Manz.  Human-hemato-lymphoid-system mice: opportunities and challenges. , 2007, Immunity.

[43]  Dale L. Greiner,et al.  Humanized mice in translational biomedical research , 2007, Nature Reviews Immunology.

[44]  L. Fugger,et al.  Humanized mouse models for organ-specific autoimmune diseases. , 2006, Current opinion in immunology.

[45]  R. Koup,et al.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection , 2006, The Journal of experimental medicine.

[46]  R. Woodland,et al.  BLyS and B cell homeostasis. , 2006, Seminars in immunology.

[47]  Philippe Morel,et al.  International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.

[48]  Philip J. R. Goulder,et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression , 2006, Nature.

[49]  R. Balderas,et al.  Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction , 2006, Nature Medicine.

[50]  T. Braun,et al.  Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[51]  S. Pascolo.  HLA class I transgenic mice: development, utilisation and improvement , 2005, Expert opinion on biological therapy.

[52]  R. Woodland,et al.  Homeostatic proliferation of B cells. , 2005, Seminars in immunology.

[53]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[54]  N. Chen,et al.  Vascular calcification in chronic kidney disease. , 2004, Seminars in nephrology.

[55]  R. Detrano,et al.  Calcification in atherosclerosis: Bone biology and chronic inflammation at the arterial crossroads , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  P. Halban,et al.  Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. , 2003, Diabetes.

[57]  C. Mathews,et al.  New mouse model to study islet transplantation in insulin-dependent diabetes mellitus , 2002, Transplantation.

[58]  D. Ron.  Proteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse. , 2002, The Journal of clinical investigation.

[59]  K. Oshimi,et al.  Differential Effects of Anti-Fas Ligand and Anti-Tumor Necrosis Factor α Antibodies on Acute Graft-Versus-Host Disease Pathologies , 1998 .

[60]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever. , 2014 .

[61]  K. Oshimi,et al.  Differential effects of anti-Fas ligand and anti-tumor necrosis factor alpha antibodies on acute graft-versus-host disease pathologies. , 1998, Blood.

[62]  Masato Yoshioka,et al.  A Novel Locus, Mody4, Distal to D7Mit189 on Chromosome 7 Determines Early-Onset NIDDM in Nonobese C57BL/6 (Akita) Mutant Mice , 1997, Diabetes.

[63]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[64]  D. Gubler,et al.  Dengue/dengue hemorrhagic fever: the emergence of a global health problem. , 1995, Emerging infectious diseases.

[65]  V. Stewart,et al.  RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.

[66]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[67]  J. Dick,et al.  Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. , 1992, Science.

[68]  I. Weissman,et al.  The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. , 1988, Science.

[69]  Donald E. Mosier,et al.  Transfer of a functional human immune system to mice with severe combined immunodeficiency , 1988, Nature.

[70]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[71]  S. Flanagan,et al.  'Nude', a new hairless gene with pleiotropic effects in the mouse. , 1966, Genetical research.